Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- rifaximin
- Zokinvy (lonafarnib)
Interactions between your drugs
rifAXIMin lonafarnib
Applies to: rifaximin, Zokinvy (lonafarnib)
Lonafarnib may increase the blood levels and effects of rifAXIMin in some patients. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
lonafarnib food/lifestyle
Applies to: Zokinvy (lonafarnib)
Lonafarnib should be taken with the morning and evening meals and an adequate amount of water. Do not consume grapefruit, grapefruit juice, or Seville oranges (also known as bitter or sour oranges).During treatment with lonafarnib. Juice from grapefruits and Seville oranges can increase the blood levels of lonafarnib. This may increase the risk and/or severity of side effects such as nausea, vomiting, diarrhea, loss of appetite, electrolyte (e.G., calcium, magnesium, potassium, phosphate, sodium) abnormalities, liver problems, low red and white blood cell counts, infection, and high blood pressure. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Duphalac
Duphalac is a laxative used to treat chronic constipation by drawing water into the colon ...
Kristalose
Kristalose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Generlac
Generlac is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Neomycin
Neomycin is used for bowel preparation, diarrhea, hepatic coma, hepatic encephalopathy
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.